|
GB9127062D0
(en)
*
|
1991-12-20 |
1992-02-19 |
Unilever Plc |
Lip treatment composition
|
|
WO1994013257A1
(en)
*
|
1992-12-16 |
1994-06-23 |
Creative Products Resource Associates, Ltd. |
Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
|
|
JP3566739B2
(ja)
*
|
1993-09-30 |
2004-09-15 |
三省製薬株式会社 |
皮膚外用剤の安定化方法
|
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
CA2197319C
(en)
*
|
1994-08-29 |
2009-01-27 |
Louis S. Kucera |
Lipid analogs for treating viral infections
|
|
US5614489A
(en)
*
|
1995-05-25 |
1997-03-25 |
Mohammadi; Fatemeh |
Method and composition for treating the skin
|
|
FR2736827B1
(fr)
*
|
1995-07-21 |
1997-09-19 |
Boucher Christine Bernard |
Huile cosmetique extraite des plantes du genre calophyllum
|
|
FR2737118B1
(fr)
*
|
1995-07-28 |
1997-09-05 |
Oreal |
Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
|
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
|
DE19720083A1
(de)
*
|
1997-05-14 |
1998-11-19 |
Silvia Zender |
Arzneimittel
|
|
US5962504A
(en)
|
1997-09-08 |
1999-10-05 |
Georgetown University |
Substituted 2-pyrrolidinone activators of PKC
|
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
|
US6156745A
(en)
*
|
1997-12-29 |
2000-12-05 |
Research Corporation Technologies, Inc. |
2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors
|
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
|
US6051603A
(en)
*
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
|
US6432941B1
(en)
*
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
|
US7141603B2
(en)
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
|
DE19825856A1
(de)
*
|
1998-06-10 |
1999-12-16 |
Labtec Gmbh |
Topische Arzneimittelzubereitung
|
|
US6355678B1
(en)
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
|
AUPP583198A0
(en)
*
|
1998-09-11 |
1998-10-01 |
Soltec Research Pty Ltd |
Mousse composition
|
|
US8263580B2
(en)
*
|
1998-09-11 |
2012-09-11 |
Stiefel Research Australia Pty Ltd |
Vitamin formulation
|
|
JP3211027B2
(ja)
*
|
1998-11-13 |
2001-09-25 |
丸石製薬株式会社 |
カプサイシン含有外用剤
|
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
KR20010102543A
(ko)
|
1999-03-09 |
2001-11-15 |
로렌스 티. 마이젠헬더 |
항바이러스제로서의4-옥소-4,7-디히드로-티에노[2,3-ｂ]피리딘-5-카르복스아미드
|
|
US6258820B1
(en)
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
|
CA2374003C
(en)
*
|
1999-05-17 |
2008-02-12 |
Aesgen, Inc. |
Improved cellular uptake of bioactive agents
|
|
WO2000078793A2
(en)
*
|
1999-06-22 |
2000-12-28 |
University Of Louisville Research Foundation, Inc. |
Antimicrobial agents
|
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
WO2001036431A1
(en)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
|
US6967023B1
(en)
*
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
|
IL133968A0
(en)
*
|
2000-01-10 |
2001-04-30 |
Thixo Ltd |
Therapeutic oils and edible pastes containing the same
|
|
MXPA02009249A
(es)
|
2000-03-21 |
2003-03-12 |
Upjohn Co |
4-oxo-1,4-dihidro(1,8)naftiridin-3-carboxamidas como agentes antivirales.
|
|
WO2001070742A1
(en)
|
2000-03-21 |
2001-09-27 |
Pharmacia & Upjohn Company |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
|
AU2001243239A1
(en)
|
2000-03-21 |
2001-11-07 |
Pharmacia And Upjohn Company Llc |
4-hydroxycinnoline-3-carboxyamides as antiviral agents
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
US6682892B2
(en)
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
|
AU2001294959A1
(en)
*
|
2000-09-29 |
2002-04-08 |
Robert M. Carlson |
Triterpenes having antibacterial activity
|
|
WO2002026761A1
(en)
|
2000-09-29 |
2002-04-04 |
Regents Of The University Of Minnesota |
Triterpenes having fungicidal activity against yeast
|
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
|
US6958359B1
(en)
*
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
|
WO2002060936A2
(en)
*
|
2001-01-31 |
2002-08-08 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
EP1397326A2
(en)
*
|
2001-05-29 |
2004-03-17 |
Koninklijke Philips Electronics N.V. |
Metal-ceramic bond
|
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
|
JP2005502687A
(ja)
*
|
2001-07-24 |
2005-01-27 |
アラムクス エルエルシー |
β−ラクタマーゼ阻害剤としての７−アルキリデン−３−置換型−３−セフェム−４−カルボキシラート
|
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
|
EP1423976A1
(en)
*
|
2001-08-31 |
2004-06-02 |
Thomson Licensing S.A. |
Sequence counter for an audio visual stream
|
|
US20040116350A1
(en)
*
|
2001-09-17 |
2004-06-17 |
Paul Wentworth Jr |
Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
|
|
US20040157280A1
(en)
*
|
2001-09-17 |
2004-08-12 |
Paul Wentworth |
Antibody mediated ozone generation
|
|
US20050129680A1
(en)
*
|
2001-09-17 |
2005-06-16 |
Paul Wentworth |
Antimicrobial activity of antibodies
|
|
AU2002362443B2
(en)
*
|
2001-10-01 |
2008-05-15 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
|
|
WO2003031587A2
(en)
*
|
2001-10-09 |
2003-04-17 |
The Regents Of The University Of California |
Use of stat-6 inhibitors as therapeutic agents
|
|
KR20050044491A
(ko)
|
2001-11-14 |
2005-05-12 |
루트거스, 더 스테이트 유니버시티 |
가용화된 토포이소머라제 독
|
|
AU2002357762A1
(en)
*
|
2001-11-23 |
2003-06-10 |
Theodore James Anastasion |
Improved synthesis of polyanhyrides
|
|
US7030141B2
(en)
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
CA2474306A1
(en)
*
|
2002-01-25 |
2003-08-07 |
Regents Of The University Of Minnesota |
Selective analgesic agents
|
|
AU2003224874A1
(en)
*
|
2002-04-04 |
2003-10-27 |
Alamx, L.L.C. |
INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
|
|
AUPS158502A0
(en)
*
|
2002-04-08 |
2002-05-16 |
Dermcare-Vet Pty Ltd |
Allergic dermatitis composition and method of treatment
|
|
JP2006515829A
(ja)
*
|
2002-04-10 |
2006-06-08 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
炎症性疾病の処置のための、ａ２ａアデノシン受容体アゴニストの使用
|
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
|
CA2493764C
(en)
*
|
2002-08-01 |
2011-05-24 |
Aesgen, Inc. |
Improved treatment of cancer with glutamine
|
|
AU2003265406A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted topoisomerase agents
|
|
US7438918B2
(en)
*
|
2002-08-30 |
2008-10-21 |
University Of Iowa Research Foundation |
Lipid A deficient mutants of Neisseria meningitidis
|
|
CA2497003A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Warner-Lambert Company Llc |
Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
|
|
WO2004032599A2
(en)
|
2002-10-10 |
2004-04-22 |
Cornell Research Foundation, Inc. |
Novel immunogenic proteins of leptospira
|
|
AU2003301353A1
(en)
*
|
2002-10-18 |
2004-05-04 |
Cylene Pharmaceuticals |
Processes for identifying quadruplex-targeted antiviral molecules
|
|
IL152486A0
(en)
*
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
|
US7704518B2
(en)
*
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US20050186142A1
(en)
*
|
2002-10-25 |
2005-08-25 |
Foamix Ltd. |
Kit and composition of imidazole with enhanced bioavailability
|
|
US7544674B2
(en)
*
|
2002-10-25 |
2009-06-09 |
Galderma S.A. |
Topical skin care composition
|
|
US10117812B2
(en)
*
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US8486376B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US20070292355A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Anti-infection augmentation foamable compositions and kit and uses thereof
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US20080206161A1
(en)
*
|
2002-10-25 |
2008-08-28 |
Dov Tamarkin |
Quiescent foamable compositions, steroids, kits and uses thereof
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US20060018937A1
(en)
*
|
2002-10-25 |
2006-01-26 |
Foamix Ltd. |
Steroid kit and foamable composition and uses thereof
|
|
US20050271596A1
(en)
*
|
2002-10-25 |
2005-12-08 |
Foamix Ltd. |
Vasoactive kit and composition and uses thereof
|
|
US20070292359A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US20060193789A1
(en)
*
|
2002-10-25 |
2006-08-31 |
Foamix Ltd. |
Film forming foamable composition
|
|
US8119109B2
(en)
*
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
BR0314916A
(pt)
*
|
2002-10-25 |
2005-08-16 |
Foamix Ltd |
Espuma farmacêutica e cosmética
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US7700076B2
(en)
*
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US20080317679A1
(en)
*
|
2002-10-25 |
2008-12-25 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
|
US20050205086A1
(en)
*
|
2002-10-25 |
2005-09-22 |
Foamix Ltd. |
Retinoid immunomodulating kit and composition and uses thereof
|
|
EP2336179A1
(en)
|
2002-11-08 |
2011-06-22 |
Ablynx N.V. |
Stabilized single domain antibodies
|
|
WO2004041867A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
|
|
US20060292076A1
(en)
*
|
2002-11-14 |
2006-12-28 |
Paul Wentworth |
Antimicrobial mediated ozone generation
|
|
US7297340B2
(en)
*
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
|
KR20080113286A
(ko)
|
2003-01-10 |
2008-12-29 |
아블린쓰 엔.브이. |
폰 빌레브란트 인자(ｖＷＦ) 또는 콜라겐에 대한 낙타과로부터의 재조합 ＶＨＨ 단일 도메인 항체
|
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
|
US7163948B2
(en)
*
|
2003-04-07 |
2007-01-16 |
Cylene Pharmaceuticals, Inc. |
Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
|
|
AU2004229489B2
(en)
*
|
2003-04-07 |
2010-03-04 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs
|
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
DE602004012279T3
(de)
|
2003-06-25 |
2010-07-15 |
The Burnham Institute, La Jolla |
Katecholderivate zur behandlung von krebs
|
|
WO2005003140A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
|
US20070140999A1
(en)
*
|
2003-07-18 |
2007-06-21 |
Hill Dermaceuticals, Inc. |
Topical skin care composition containing refined peanut oil
|
|
US7169401B2
(en)
*
|
2003-07-18 |
2007-01-30 |
Hill Dermaceuticals, Inc. |
Topical skin care composition containing refined peanut oil
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
US8486374B2
(en)
*
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
ES2440467T3
(es)
|
2003-08-25 |
2014-01-29 |
Dogwood Pharmaceuticals, Inc. |
8-heteroaril xantinas substituidas
|
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
|
US20060099173A1
(en)
*
|
2003-10-24 |
2006-05-11 |
Nancy Puglia |
Topical skin care composition
|
|
DE60334645D1
(de)
|
2003-11-07 |
2010-12-02 |
Ablynx Nv |
Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
|
|
ATE502298T1
(de)
*
|
2003-12-19 |
2011-04-15 |
Univ California |
Verfahren und materialien zur beurteilung von prostatakrebstherapien
|
|
ZA200507017B
(en)
*
|
2004-02-04 |
2007-03-28 |
Foamix Ltd |
Cosmetic and pharmaceutical foam with solid matter
|
|
US20060003948A1
(en)
*
|
2004-02-06 |
2006-01-05 |
Krasutsky Pavel A |
Compositions that include a triterpene and a carrier
|
|
ES2554330T3
(es)
|
2004-02-19 |
2015-12-18 |
Rexahn Pharmaceuticals, Inc. |
Derivados de quinazolina y uso terapéutico de los mismos
|
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
|
AU2005232526B2
(en)
*
|
2004-02-24 |
2011-06-23 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
|
US8435959B2
(en)
|
2004-03-29 |
2013-05-07 |
University Of South Florida |
Effective treatment of tumors and cancer with triciribine and related compounds
|
|
EP2266994B1
(en)
|
2004-08-02 |
2013-04-03 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analgos with modified 5'-ribose groups having A2A agonist activity
|
|
WO2006028618A1
(en)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
|
US7268124B2
(en)
*
|
2004-08-25 |
2007-09-11 |
University Of Iowa Research Foundation |
Geranylgeranyl pyrophosphate synthase inhibitors
|
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
|
CA2583017A1
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease
|
|
US8697674B2
(en)
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
|
WO2006086103A2
(en)
*
|
2005-01-10 |
2006-08-17 |
University Of Virginia Patent Foundation |
Synthesis of inhibitors of p90rsk
|
|
JP2008540511A
(ja)
*
|
2005-05-09 |
2008-11-20 |
フォーミックス エルティーディー． |
糖類発泡性組成物
|
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
RS52274B2
(sr)
|
2005-05-13 |
2018-05-31 |
Univ California |
Jedinjenje diarilhidantoina
|
|
HUE045710T2
(hu)
|
2005-05-18 |
2020-01-28 |
Ablynx Nv |
Javított, alfa tumor nekrózis faktor elleni nanobodies
|
|
SI2444424T1
(sl)
|
2005-05-20 |
2018-10-30 |
Ablynx N.V. |
Izboljšana protitelesa (TM) za zdravljenje z agregacijo posredovanih motenj
|
|
EP1917072B1
(en)
*
|
2005-06-01 |
2013-02-27 |
Stiefel Research Australia Pty Ltd |
Vitamin formulation
|
|
US20080152596A1
(en)
*
|
2005-07-19 |
2008-06-26 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
US7655695B2
(en)
*
|
2005-08-03 |
2010-02-02 |
The Regents Of The University Of California |
Illudin analogs useful as anticancer agents
|
|
JP2009504803A
(ja)
|
2005-08-22 |
2009-02-05 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Ｔｌｒアゴニスト
|
|
US20070098667A1
(en)
*
|
2005-10-27 |
2007-05-03 |
Jim Taneri |
Methods and compositions for epilation
|
|
US20070098660A1
(en)
*
|
2005-10-27 |
2007-05-03 |
Jim Taneri |
Methods and compositions for epilation
|
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
|
US8178509B2
(en)
*
|
2006-02-10 |
2012-05-15 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
|
EP1993558B1
(en)
|
2006-02-27 |
2014-07-30 |
The Regents of The University of California |
Oxysterol compounds and the hedgehog pathway
|
|
CN101431996A
(zh)
*
|
2006-03-22 |
2009-05-13 |
加利福尼亚大学董事会 |
蛋白质异戊二烯基转移酶的抑制剂
|
|
ES2588606T3
(es)
|
2006-03-27 |
2016-11-03 |
The Regents Of The University Of California |
Modulador del receptor de andrógenos para el tratamiento del cáncer de próstata y enfermedades asociadas con el receptor de andrógenos
|
|
SG10201408699TA
(en)
|
2006-03-29 |
2015-02-27 |
Univ California |
Diarylthiohydantoin compounds
|
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
|
WO2007139778A2
(en)
*
|
2006-05-22 |
2007-12-06 |
University Of Virginia Patent Foundation |
Rhamnose substituents of sl0101 and therapeutic uses thereof
|
|
US20110112086A1
(en)
*
|
2006-06-08 |
2011-05-12 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs
|
|
US20100305136A1
(en)
*
|
2006-06-08 |
2010-12-02 |
Johnny Yasuo Nagasawa |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
|
EP2061467A4
(en)
*
|
2006-09-08 |
2013-08-21 |
Foamix Ltd |
EXPANDABLE COMPOSITION AND FOAM COLOR OR COLORABLE
|
|
US20080206155A1
(en)
*
|
2006-11-14 |
2008-08-28 |
Foamix Ltd. |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
|
US20080260655A1
(en)
*
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
|
EP2086962A1
(en)
*
|
2006-11-29 |
2009-08-12 |
Pfizer Products Inc. |
(r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor
|
|
WO2008074840A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
|
CA2673331A1
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
US8207381B2
(en)
|
2007-02-06 |
2012-06-26 |
University Of Louisville Research Foundation |
Therapeutic compounds
|
|
EA019151B1
(ru)
|
2007-02-07 |
2014-01-30 |
Дзе Регентс Оф Дзе Юниверсити Оф Калифорния |
Конъюгаты синтетических агонистов tlr и их применение
|
|
WO2008103818A1
(en)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Therapeutic cotinine compositions
|
|
WO2009073186A1
(en)
|
2007-12-03 |
2009-06-11 |
The Regents Of The University Of California |
Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
|
|
US8569449B2
(en)
|
2007-05-08 |
2013-10-29 |
University Of Louisville Research Foundation, Inc. |
Synthetic peptides and peptide mimetics
|
|
AU2008274956B2
(en)
*
|
2007-07-12 |
2014-08-21 |
University Of South Florida |
Inhibitors of Akt/PKB with anti-tumor activity
|
|
MX2010001303A
(es)
|
2007-08-02 |
2010-09-07 |
Univ Rutgers |
Compuestos terapeuticos.
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
WO2009046383A1
(en)
|
2007-10-05 |
2009-04-09 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs and methods related thereto
|
|
EP2205088B1
(en)
*
|
2007-10-19 |
2018-02-21 |
Burnham Institute for Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
|
WO2009055677A1
(en)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Antibacterial s-heterosubstituted disulfides
|
|
PE20170428A1
(es)
|
2007-10-26 |
2017-05-14 |
Univ California |
Compuestos de diarilhidantoina
|
|
US20090130029A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Foamix Ltd. |
Glycerol ethers vehicle and pharmaceutical compositions thereof
|
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
|
WO2009090495A2
(en)
|
2007-12-07 |
2009-07-23 |
Foamix Ltd. |
Oil and liquid silicone foamable carriers and formulations
|
|
US8518376B2
(en)
|
2007-12-07 |
2013-08-27 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
WO2009090558A2
(en)
*
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
WO2009108716A2
(en)
|
2008-02-27 |
2009-09-03 |
University Of Louisville Research Foundation |
Synthetic peptides
|
|
WO2009114539A2
(en)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
|
|
US20110046101A1
(en)
*
|
2008-03-17 |
2011-02-24 |
Dmitrienko Gary I |
Bate-lactamase inhibitors
|
|
WO2009146112A1
(en)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions and methods for inhibiting sphingosine kinase
|
|
CN102056945A
(zh)
|
2008-04-07 |
2011-05-11 |
埃博灵克斯股份有限公司 |
针对Notch途径的单可变结构域
|
|
UA110918C2
(uk)
*
|
2008-04-16 |
2016-03-10 |
Ховард Юніверсіті |
Інгібітори протеїнфосфатази-1 та їх застосування
|
|
NZ589036A
(en)
|
2008-05-16 |
2012-07-27 |
Ablynx Nv |
AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
|
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
|
WO2010005534A2
(en)
*
|
2008-06-30 |
2010-01-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
US20090324506A1
(en)
*
|
2008-06-30 |
2009-12-31 |
Jeffery Richard Seidling |
Sprayable skin protectant formulation and method of use
|
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
|
US9174969B2
(en)
*
|
2008-07-21 |
2015-11-03 |
University Of South Florida |
Indoline scaffold SHP-2 inhibitors and cancer treatment method
|
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
|
WO2010014054A1
(en)
|
2008-07-28 |
2010-02-04 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
|
BRPI0917417A2
(pt)
*
|
2008-08-05 |
2015-12-01 |
Univ South Florida |
mnétodos de tratar deficiência cognitiva
|
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
AU2009279400A1
(en)
*
|
2008-08-08 |
2010-02-11 |
University Of Florida Research Foundation, Inc. |
Lipid compounds for supression of tumorigenesis
|
|
US9480691B1
(en)
*
|
2009-01-20 |
2016-11-01 |
Hill Dermaceuticals, Inc. |
Topical liquid containing refined peanut oil for treating skin proliferation or inflammation disorders
|
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
|
US20100240612A1
(en)
|
2009-03-20 |
2010-09-23 |
University Of Iowa Research Foundation |
Prenylated Bisphosphonates as Anti-tuberculosis Agents
|
|
CN105399828B
(zh)
|
2009-04-10 |
2021-01-15 |
埃博灵克斯股份有限公司 |
用于治疗il-6r相关疾病和病症的改进的针对il-6r的氨基酸序列和包含其的多肽
|
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
|
EA201101326A1
(ru)
|
2009-04-15 |
2012-05-30 |
Сэнфорд-Бёрнхэм Медикал Рисёч Инститьют |
Ингибиторы антиапоптотических белков на основе нафталина
|
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
|
ES2787599T3
(es)
|
2009-05-13 |
2020-10-16 |
Univ Virginia Patent Foundation |
Inhibidores de leucemia inv(16)
|
|
MX2012000113A
(es)
|
2009-06-30 |
2012-02-29 |
Forest Lab Holdings Ltd |
Compuestos alcoxi-carbonil-amino-alquinil-adenosina y derivados de los mismos como agonistas a2ar.
|
|
WO2011005871A1
(en)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists
|
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
CA2769209A1
(en)
|
2009-07-31 |
2011-02-03 |
Biocryst Pharmaceuticals, Inc. |
Pyrrolo [1,2-b] pyridazine derivatives as janus kinase inhibitors
|
|
WO2011019995A2
(en)
|
2009-08-14 |
2011-02-17 |
Hecht Sidney M |
Synthesis and identification of novel rsk-specific inhibitors
|
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
|
WO2011064631A1
(en)
|
2009-10-02 |
2011-06-03 |
Foamix Ltd. |
Surfactant-free, water-free, foamable compositions and breakable foams and their uses
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
EA201270347A1
(ru)
*
|
2009-10-08 |
2012-11-30 |
Санфорд-Бернхам Медикал Ресерч Инститъют |
Производные апогоссиполона в качестве противоопухолевых агентов
|
|
US8796300B2
(en)
|
2009-11-05 |
2014-08-05 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
WO2011079230A2
(en)
|
2009-12-23 |
2011-06-30 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclic compounds as janus kinase inhibitors
|
|
WO2011079305A1
(en)
|
2009-12-23 |
2011-06-30 |
Wayne State University |
Therapeutic compounds
|
|
CN102884057B
(zh)
|
2010-02-16 |
2016-09-14 |
亚拉冈制药公司 |
雄激素受体调节剂及其用途
|
|
EP2539348A4
(en)
|
2010-02-26 |
2013-07-24 |
Gary Igor Dmitrienko |
CEPHALOSPORIN DERIVATIVES AS BETA LACTAMASE HEMMER AND COMPOSITIONS THEREFOR AND METHOD FOR THEIR USE
|
|
JP2013523777A
(ja)
|
2010-04-02 |
2013-06-17 |
ティーエスアールエル インコーポレイテッド |
ノイラミニダーゼ阻害剤
|
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
|
WO2011133696A2
(en)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Methods of suppressing atherosclerosis
|
|
TW201202246A
(en)
|
2010-05-28 |
2012-01-16 |
Biocryst Pharm Inc |
Heterocyclic compounds as JANUS kinase inhibitors
|
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
|
WO2012027495A1
(en)
|
2010-08-27 |
2012-03-01 |
University Of The Pacific |
Piperazinylpyrimidine analogues as protein kinase inhibitors
|
|
US11819563B2
(en)
|
2010-09-20 |
2023-11-21 |
L'oreal |
Aqueous cosmetic composition comprising alkylcellulose
|
|
JP5774706B2
(ja)
|
2010-09-20 |
2015-09-09 |
ロレアルＬ′Ｏｒｅａｌ |
アルキルセルロースを含む水性化粧料組成物
|
|
CA2816021A1
(en)
|
2010-10-25 |
2012-05-10 |
Regents Of The University Of Minnesota |
Therapeutic composition for treatment of glioblastoma
|
|
DK2672823T3
(en)
|
2011-02-07 |
2016-11-28 |
Biogen Ma Inc |
S1P-modulating agents
|
|
WO2012122219A2
(en)
|
2011-03-07 |
2012-09-13 |
University Of Louisville Research Foundation |
Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
|
|
WO2012135697A2
(en)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Novel rho kinase inhibitors and methods of use
|
|
CA2834734A1
(en)
|
2011-04-04 |
2012-10-11 |
University Of Iowa Research Foundation |
Methods of improving vaccine immunogenicity
|
|
US20140030341A1
(en)
|
2011-04-06 |
2014-01-30 |
Rutgers, The State University Of New Jersey |
Polymers and methods for the treatment of pain
|
|
US20120270860A1
(en)
|
2011-04-19 |
2012-10-25 |
Gihyun Yoon |
Methods for treating or preventing alcohol-related disorders or craving-related disorders
|
|
WO2012145678A1
(en)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Anti-cancer and anti-inflammatory parthenolide compounds
|
|
WO2012177770A1
(en)
|
2011-06-20 |
2012-12-27 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial rna polymerase
|
|
WO2013009647A1
(en)
|
2011-07-08 |
2013-01-17 |
Regents Of The University Of Minnesota |
Glutathione analogs and uses thereof
|
|
AU2012287103B2
(en)
|
2011-07-22 |
2017-03-30 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
|
EP3610731A1
(en)
|
2011-07-29 |
2020-02-19 |
Medivation Prostate Therapeutics LLC |
Treatment of breast cancer
|
|
WO2013028866A1
(en)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
WO2013033345A1
(en)
|
2011-08-30 |
2013-03-07 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
US9598441B2
(en)
|
2011-08-30 |
2017-03-21 |
Wayne State University |
Therapeutic compounds and methods
|
|
WO2013036931A1
(en)
|
2011-09-08 |
2013-03-14 |
Western University Of Health Sciences |
Targeted liposomes in cancer therapy
|
|
US9573906B2
(en)
|
2011-09-15 |
2017-02-21 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Therapeutic compounds
|
|
US9828326B2
(en)
*
|
2011-12-27 |
2017-11-28 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
|
FR2985176B1
(fr)
|
2012-01-02 |
2015-05-29 |
Oreal |
Composition cosmetique liquide aqueuse comprenant de l'alkylcellulose, des huiles non volatiles et au moins un tensioactif
|
|
WO2013103969A1
(en)
|
2012-01-05 |
2013-07-11 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
|
US9512212B2
(en)
|
2012-01-11 |
2016-12-06 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
US8947424B2
(en)
|
2012-01-17 |
2015-02-03 |
Eastman Kodak Company |
Spectral stereoscopic projection system
|
|
EP2804606B1
(en)
|
2012-01-19 |
2017-06-28 |
Hybrid Medical, LLC |
Topical therapeutic formulations
|
|
US9296728B2
(en)
|
2012-01-20 |
2016-03-29 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
|
CA2863427C
(en)
|
2012-02-01 |
2022-07-12 |
The Governors Of The University Of Alberta |
Use of pdgfr-.alpha. as diagnostic marker for papillary thyroid cancer
|
|
WO2013119564A1
(en)
|
2012-02-06 |
2013-08-15 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
|
EP2822548B1
(en)
|
2012-02-08 |
2019-04-24 |
University of Virginia Patent Foundation |
Long chain base sphingosine kinase inhibitors
|
|
US9187446B2
(en)
|
2012-03-22 |
2015-11-17 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechainfluorinated myxopyronin derivatives
|
|
CN104583203B
(zh)
|
2012-03-26 |
2017-06-13 |
衣阿华大学研究基金会 |
Schweinfurthin类似物
|
|
US9340501B2
(en)
|
2012-04-16 |
2016-05-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Marinopyrrole derivatives as anticancer agents
|
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
|
RU2632191C2
(ru)
|
2012-05-07 |
2017-10-03 |
Те Риджентс Оф Те Юниверсити Оф Калифорния |
Аналог оксистерола oxy133 индуцирует остеогенез и сигнальный путь hedgehog и ингибирует липогенез
|
|
US9315495B2
(en)
|
2012-06-19 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: aryl myxopyronin derivatives
|
|
US9492448B2
(en)
|
2012-06-20 |
2016-11-15 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating glucose homeostasis and insulin action
|
|
US9669115B2
(en)
|
2012-06-29 |
2017-06-06 |
University Of Iowa Research Foundation |
Co-crystals and salts of contrast agents and imaging
|
|
WO2014008407A1
(en)
|
2012-07-05 |
2014-01-09 |
University Of Iowa Research Foundation |
Therapeutic bisphosphonates
|
|
EP2875029B8
(en)
|
2012-07-18 |
2021-12-15 |
University of Notre Dame du Lac |
5,5-heteroaromatic anti-infective compounds
|
|
WO2014018671A1
(en)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds for the treatment of cancer
|
|
US9522889B2
(en)
|
2012-07-27 |
2016-12-20 |
Biogen Ma Inc. |
ATX modulating agents
|
|
MX367879B
(es)
|
2012-08-01 |
2019-09-10 |
Lewis And Clark Pharmaceuticals Inc |
N-alquil 2-(disustituido)alquiladenosin-5-uronamidas como agonistas a2a.
|
|
KR102157912B1
(ko)
|
2012-08-03 |
2020-09-21 |
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 |
효소-활성화 화합물 및 조성물
|
|
US9499485B2
(en)
|
2012-08-06 |
2016-11-22 |
Biogen Ma Inc. |
Compounds that are S1P modulating agents and/or ATX modulating agents
|
|
WO2014025708A1
(en)
|
2012-08-06 |
2014-02-13 |
Biogen Idec Ma Inc. |
Compounds that are s1p modulating agents and/or atx modulating agents
|
|
WO2014031732A2
(en)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methods for inhibiting fascin
|
|
WO2014039860A2
(en)
|
2012-09-07 |
2014-03-13 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating dnmt1 inhibitor activity
|
|
US9573938B2
(en)
|
2012-09-11 |
2017-02-21 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
|
SG10201902568YA
(en)
|
2012-09-26 |
2019-04-29 |
Aragon Pharmaceuticals Inc |
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
|
|
EP2906207A4
(en)
|
2012-10-10 |
2016-10-26 |
Univ Arizona State |
MULTIFUNCTIONAL RADICAL QUENCHER
|
|
WO2014059350A1
(en)
|
2012-10-12 |
2014-04-17 |
Regents Of The University Of Minnesota |
Open chained or fused 1,1 '-alkylene-bis-uracil derivatives, useful in skin uv-protection
|
|
WO2014066840A1
(en)
|
2012-10-26 |
2014-05-01 |
Regents Of The University Of Minnesota |
Aurora kinase inhibitors
|
|
US10519161B2
(en)
|
2012-10-29 |
2019-12-31 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
|
WO2014074926A1
(en)
|
2012-11-09 |
2014-05-15 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
|
WO2014078778A2
(en)
|
2012-11-16 |
2014-05-22 |
Biocryst Pharmaceuticals, Inc. |
Antiviral azasugar-containing nucleosides
|
|
US9670199B2
(en)
|
2012-11-19 |
2017-06-06 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
|
ES2636596T3
(es)
|
2012-11-20 |
2017-10-06 |
Biogen Ma Inc. |
Agentes moduladores de S1P y/o ATX
|
|
EP2922821B1
(en)
|
2012-11-20 |
2019-07-31 |
Biogen MA Inc. |
S1p and/or atx modulating agents
|
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
|
US9700044B2
(en)
|
2013-01-22 |
2017-07-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Symmetrical marinopyrrole derivatives as potential antibiotic agents
|
|
US9765016B2
(en)
|
2013-01-29 |
2017-09-19 |
Biogen Ma Inc. |
S1P modulating agents
|
|
US9981043B2
(en)
|
2013-02-08 |
2018-05-29 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
|
WO2014138302A1
(en)
|
2013-03-05 |
2014-09-12 |
University Of Notre Dame |
Quinazolinone antibiotics
|
|
WO2014143672A1
(en)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
|
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
|
AR095328A1
(es)
|
2013-03-15 |
2015-10-07 |
Biogen Idec Inc |
Agentes de modulación de s1p y/o atx
|
|
JP2016519672A
(ja)
|
2013-03-15 |
2016-07-07 |
ジェネンテック， インコーポレイテッド |
ブロモドメイン含有タンパク質ｂｒｄ７およびｂｒｄ９の阻害によるｔｈ２媒介性疾患の治療
|
|
WO2014179756A1
(en)
|
2013-05-02 |
2014-11-06 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol-bone targeting agents
|
|
US9862672B2
(en)
|
2013-05-29 |
2018-01-09 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
|
WO2015003095A1
(en)
|
2013-07-03 |
2015-01-08 |
Regents Of The University Of Minnesota |
Sunless tanning compounds and compositions
|
|
CN105592850B
(zh)
|
2013-08-06 |
2019-11-15 |
H·李·莫菲特癌症中心研究所公司 |
Ack1/tnk2酪氨酸激酶的抑制剂
|
|
WO2015070226A1
(en)
|
2013-11-11 |
2015-05-14 |
Kuality Herbceutics Llc |
Kava derived therapeutic compounds and methods of use thereof
|
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
|
WO2015120320A1
(en)
|
2014-02-06 |
2015-08-13 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides
|
|
CA2940144C
(en)
|
2014-02-20 |
2023-06-13 |
Cornell University |
Substituted indazol-3-yl derivatives and pharmaceutical compositions thereof useful as inhibitor of fascin
|
|
WO2015130805A1
(en)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dna gridiron compositions and methods
|
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
SI3113772T1
(sl)
|
2014-03-07 |
2021-01-29 |
Biocryst Pharmaceuticals, Inc. |
S trifluorometilom substituirani pirazoli kot inhibitorji plazemskih kalikreinov pri človeku
|
|
WO2015153560A1
(en)
|
2014-03-31 |
2015-10-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
|
US10266603B2
(en)
|
2014-04-18 |
2019-04-23 |
The Governors Of The University Of Alberta |
Targeted therapy to restore radioactive iodine transport in thyroid cancer
|
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
|
WO2015168636A1
(en)
|
2014-05-02 |
2015-11-05 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol bisphosphonate analogs
|
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
|
EP3152206A1
(en)
|
2014-06-06 |
2017-04-12 |
Biogen MA Inc. |
Atx modulating agents
|
|
US10138203B2
(en)
|
2014-06-16 |
2018-11-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
|
US11149046B2
(en)
|
2014-08-19 |
2021-10-19 |
Hsiri Therapeutics, Inc. |
Antibacterial sideromycins
|
|
CA2964239C
(en)
|
2014-09-11 |
2022-12-13 |
University Of Iowa Research Foundation |
Thymol and carvacol for use in medicine
|
|
US10920195B2
(en)
|
2014-11-13 |
2021-02-16 |
University Of Iowa Research Foundation |
Methods to generate epithelial cells
|
|
EP3259254B1
(en)
|
2015-02-17 |
2020-07-01 |
Arizona Board of Regents on behalf of Arizona State University |
Deuterated and undeuterated 2-amino-pyrimidin-5-ol derivatives for treating mitochondrial diseases (e.g. obesity)
|
|
WO2016133995A1
(en)
|
2015-02-17 |
2016-08-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Phenothiazine analogues as mitochondrial therapeutic agents
|
|
US10507228B2
(en)
|
2015-04-20 |
2019-12-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods and compositions related to KRAS inhibitors
|
|
CA2985184A1
(en)
|
2015-05-06 |
2016-11-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Radiotherapeutic and companion imaging agents to target mc1r
|
|
US10584108B2
(en)
|
2015-05-07 |
2020-03-10 |
Kuality Herbceutics Llc |
Therapeutic compounds and methods of use thereof
|
|
EP3297655B1
(en)
|
2015-05-18 |
2020-04-15 |
Arizona Board of Regents on Behalf of the University of Arizona |
Enhanced melanoma cancer prevention by novel melanotropins
|
|
US11369569B2
(en)
|
2015-06-15 |
2022-06-28 |
University Of Virginia Patent Foundation |
Target-specific delivery of therapeutic agents
|
|
US10308663B2
(en)
|
2015-06-16 |
2019-06-04 |
University Of Virginia Patent Foundation |
Inhibitors of PTP4A3 for the treatment of cancer
|
|
US10814006B2
(en)
|
2015-07-14 |
2020-10-27 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
|
EP3328372A4
(en)
|
2015-07-28 |
2019-03-20 |
University Of Iowa Research Foundation |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
|
|
US10336734B2
(en)
|
2015-08-02 |
2019-07-02 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ACK1/TNK2 tyrosine kinase
|
|
WO2017027883A1
(en)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
|
WO2017040772A1
(en)
|
2015-09-04 |
2017-03-09 |
Janssen Pharmaceutica Nv |
Therapeutic compounds and synthesis
|
|
TWI796714B
(zh)
|
2015-10-01 |
2023-03-21 |
美商百歐克斯製藥公司 |
人類血漿激肽釋放酶抑制劑
|
|
SG10201912703PA
(en)
|
2015-10-01 |
2020-02-27 |
Goleini Inc |
Targeted expression of chloride channels and methods of use thereof
|
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
|
CA3004048A1
(en)
|
2015-11-03 |
2017-05-11 |
Regents Of The University Of Minnesota |
Cd200 inhibitors and methods of use thereof
|
|
US10857156B2
(en)
|
2015-11-20 |
2020-12-08 |
Senhwa Biosciences, Inc. |
Combination therapy of tetracyclic quinolone analogs for treating cancer
|
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
|
EP3393436B1
(en)
|
2015-12-21 |
2023-06-07 |
L'oreal |
Composition comprising alkylcellulose, incompatible hydrocarbon and silicone oils and method employing it
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
TWI854164B
(zh)
|
2016-02-01 |
2024-09-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
|
MX394516B
(es)
|
2016-03-16 |
2025-03-24 |
H Lee Moffitt Cancer Ct & Res |
Moléculas pequeñas contra cereblon para mejorar la función efectora de los linfocitos t.
|
|
CA3018750A1
(en)
|
2016-03-22 |
2017-09-28 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
CN109219610A
(zh)
|
2016-04-04 |
2019-01-15 |
新泽西州立拉特格斯大学 |
拓扑异构酶毒物
|
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
|
CA3021446A1
(en)
|
2016-04-18 |
2017-10-26 |
Kenneth Michael MORROW |
Isolation of plant extracts
|
|
CA3023225A1
(en)
|
2016-05-04 |
2017-11-09 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
|
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
|
RU2019101420A
(ru)
|
2016-06-20 |
2020-07-21 |
Ратгерс, Де Стейт Юниверсити Оф Нью Джерси |
Терапевтические соединения
|
|
EP3474879A4
(en)
|
2016-06-24 |
2020-05-06 |
University of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
|
ES2937307T3
(es)
|
2016-07-26 |
2023-03-27 |
Univ Southern California |
Inhibición selectiva del bromodominio del BDF1 fúngico
|
|
WO2018039077A1
(en)
|
2016-08-25 |
2018-03-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
|
RU2019114964A
(ru)
|
2016-10-17 |
2020-11-17 |
Дженентек, Инк. |
Терапевтические средства и способы их применения
|
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
|
DK3532057T3
(da)
|
2016-10-31 |
2023-02-20 |
Biocryst Pharm Inc |
Prodrugs af kallikreininhibitorer
|
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
|
CA3044814A1
(en)
|
2016-11-29 |
2018-06-07 |
Charles M. Brenner |
Use of nad precursors for improving maternal health and/or offspring health
|
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
|
JP2020505357A
(ja)
|
2017-01-20 |
2020-02-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
アンドロゲン受容体のｎ末端ドメインの阻害剤
|
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
|
WO2018140504A1
(en)
|
2017-01-24 |
2018-08-02 |
Patel Manoj K |
Compositions and methods for blocking sodium channels
|
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
|
WO2018209355A1
(en)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Therapeutic methods and compositions
|
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
|
US11896591B2
(en)
|
2017-05-22 |
2024-02-13 |
University Of Virginia Patent Foundation |
Compositions and methods for preparing and using mitochondrial uncouplers
|
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
WO2018237134A1
(en)
|
2017-06-23 |
2018-12-27 |
San Diego State University Research Foundation |
ATROPISOMERISM FOR ENHANCED SELECTIVITY OF KINASE INHIBITORS
|
|
EP3676255B1
(en)
|
2017-08-29 |
2025-04-16 |
Rutgers, The State University University Of New Jersey |
Therapeutic indazoles
|
|
TW201932100A
(zh)
|
2017-08-30 |
2019-08-16 |
美國亞利桑那州立大學亞利桑那州評議委員會 |
Ｒｎａ奈米結構及製備與使用ｒｎａ奈米結構之方法
|
|
MX2020003551A
(es)
|
2017-10-06 |
2020-12-10 |
Blue Therapeutics Inc |
Metodos de tratamiento de dolor agudo o cronico.
|
|
EP4438126A3
(en)
|
2017-10-16 |
2025-01-01 |
Aragon Pharmaceuticals, Inc. |
Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
|
|
IL274663B2
(en)
|
2017-11-17 |
2024-01-01 |
Univ Illinois |
Cancer therapy by degrading dual mek signaling
|
|
CA3082827A1
(en)
|
2017-11-17 |
2019-05-23 |
Cytogel Pharma, Llc |
Polymer agonists of mu opioid receptors
|
|
CN111683654A
(zh)
|
2017-11-30 |
2020-09-18 |
细胞凝胶制药有限责任公司 |
新型镇痛药物制剂及其用途
|
|
WO2019140140A1
(en)
|
2018-01-10 |
2019-07-18 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Rna-nanostructured double robots and methods of use thereof
|
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
|
CN112118837B
(zh)
|
2018-02-13 |
2024-07-09 |
罗格斯新泽西州立大学 |
抗菌剂：o-烷基氘化派洛宁
|
|
CN112334133A
(zh)
|
2018-02-15 |
2021-02-05 |
生华生物科技股份有限公司 |
喹诺酮类似物及其盐、组合物及其使用方法
|
|
WO2019168921A1
(en)
|
2018-02-27 |
2019-09-06 |
University Of Virginia Patent Foundation |
Plectin-targeted liposomes/parp inhibitor in the treatment of cancer
|
|
WO2019173507A1
(en)
|
2018-03-06 |
2019-09-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents : arylalkylcarboxamido phloroglucinols
|
|
TWI873092B
(zh)
|
2018-04-06 |
2025-02-21 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
|
WO2019204819A1
(en)
|
2018-04-20 |
2019-10-24 |
Virginia Tech Intellectual Properties, Inc. |
Aminopyrazines and related compounds useful as mitochondrial uncouplers
|
|
US12344845B2
(en)
|
2018-04-27 |
2025-07-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Highly knotted molecular topologies from single-stranded nucleic acids
|
|
WO2019240884A2
(en)
|
2018-04-27 |
2019-12-19 |
University Of Iowa Research Foundation |
Compositions for chelating metals at low temperatures
|
|
EP3810641A4
(en)
|
2018-06-19 |
2022-07-13 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
ONCOLYTIC VIRUS OR ANTIGEN PRESENT CELL MEDIATED CANCER THERAPY USING TYPE I INTERFERON AND CD40 LIGAND
|
|
US10758594B2
(en)
|
2018-06-26 |
2020-09-01 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for treatment of skin abnormalities
|
|
US10912822B2
(en)
|
2018-06-26 |
2021-02-09 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for guided tissue regeneration
|
|
AU2019301679A1
(en)
|
2018-07-11 |
2021-01-28 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
|
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
|
WO2020028814A1
(en)
|
2018-08-03 |
2020-02-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of wee1 kinase
|
|
US20210315886A1
(en)
|
2018-08-09 |
2021-10-14 |
The Board Of Trustees Of The University Of Illinois |
Imidazotetrazine compounds
|
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
|
US12319685B2
(en)
|
2018-08-17 |
2025-06-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors
|
|
JP6933394B2
(ja)
*
|
2018-09-06 |
2021-09-08 |
マリン エッセンス バイオサイエンシズ コーポレーション オブ ユーエスエーＭａｒｉｎｅ Ｅｓｓｅｎｃｅ Ｂｉｏｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ ｏｆ ＵＳＡ |
組織再生誘導のためのバイオマテリアルデバイスおよび局所用組成物
|
|
US12162856B2
(en)
|
2018-10-18 |
2024-12-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
β-catenin and B-cell lymphoma 9 (BCL9) inhibitors
|
|
EP3877439A4
(en)
|
2018-11-07 |
2022-08-10 |
Regents of the University of Minnesota |
ANALGESIC AND ANTI-ADDICTION PROTECTIVE COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND OPIOID ADDICTION
|
|
WO2020112889A2
(en)
|
2018-11-26 |
2020-06-04 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
|
US12269899B2
(en)
|
2018-12-07 |
2025-04-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Peptidomimetic inhibitors of β-catenin/Tcf protein-protein interaction
|
|
WO2020150149A1
(en)
|
2019-01-14 |
2020-07-23 |
Regents Of The University Of Minnesota |
Cd200ar ligands for cancer immunotherapy
|
|
US10889601B2
(en)
|
2019-02-11 |
2021-01-12 |
University Of Iowa Research Foundation |
Separations using boron containing hydrocarbon sponges
|
|
WO2020225779A1
(en)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Rig-i agonists for cancer treatment and immunotherapy
|
|
US20220411398A1
(en)
|
2019-06-24 |
2022-12-29 |
University Of Iowa Research Foundation |
Jnk inhibitors as anticancer agents
|
|
US11840703B2
(en)
|
2019-07-01 |
2023-12-12 |
Matrexa LLC |
Recombinant versican isoforms and related compositions and methods
|
|
CN114206839B
(zh)
|
2019-08-06 |
2025-03-07 |
拜奥克里斯特制药公司 |
血浆激肽释放酶抑制剂的生产规模合成
|
|
UY38912A
(es)
|
2019-10-09 |
2021-05-31 |
Biocryst Pharm Inc |
Inhibidores del factor d del complemento para administración oral
|
|
US12234578B2
(en)
|
2020-01-29 |
2025-02-25 |
Wisconsin Alumni Research Foundation |
Tannin composite fibers
|
|
AR121715A1
(es)
|
2020-04-03 |
2022-06-29 |
Biocryst Pharm Inc |
Pirrolopirimidinaminas como inhibidores del sistema del complemento
|
|
US20230146256A1
(en)
|
2020-04-17 |
2023-05-11 |
Regents Of The University Of Minnesota |
SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF
|
|
US12318469B2
(en)
|
2020-06-30 |
2025-06-03 |
L'oréal |
Cosmetic compositions capable of forming a multilayer structure after application to a keratinous material containing a combination of silicone resins
|
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
|
WO2022155332A1
(en)
|
2021-01-13 |
2022-07-21 |
Blue Therapeutics, Inc. |
Methods of treating irritable bowel syndrome
|
|
AU2022222781A1
(en)
|
2021-02-22 |
2023-08-24 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
US12303564B2
(en)
|
2021-03-19 |
2025-05-20 |
Wisconsin Alumni Research Foundation |
Composite chitosan-tannin-active agent compositions and methods of making and using same
|
|
US11780828B2
(en)
|
2021-05-04 |
2023-10-10 |
Regents Of The University Of Minnesota |
Contraceptive compounds and methods
|
|
US20250025447A1
(en)
|
2021-11-03 |
2025-01-23 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
|
WO2023091689A1
(en)
|
2021-11-19 |
2023-05-25 |
University Of Iowa Research Foundation |
Combined use of mcr1-directed radiotherapy and immune checkpoint inhibition in the treatment of melanoma
|
|
WO2024006977A1
(en)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
|
WO2024009283A1
(en)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
At2 antagonists for non-addictive pain relief
|
|
KR20250044681A
(ko)
|
2022-07-08 |
2025-04-01 |
액티오 바이오사이언스, 인크. |
치료용 화합물 및 방법
|
|
WO2024102342A1
(en)
|
2022-11-10 |
2024-05-16 |
University Of Iowa Research Foundation |
Combination of a glutathione synthesis inhibitor such as buthionine sulphoximine and an immune checkpoint inhibitor, preferably pembrolizumab, to treat cancer, preferably drug-resistant melanoma
|
|
WO2024112932A1
(en)
|
2022-11-23 |
2024-05-30 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
WO2024124023A2
(en)
|
2022-12-07 |
2024-06-13 |
Rutgers, The State University Of New Jersey |
Carbonic anhydrase enzyme inhibitors and methods of use thereof
|
|
WO2024197165A1
(en)
|
2023-03-21 |
2024-09-26 |
University Of Iowa Research Foundation |
Broad spectrum antifungal keto-alkyl-pyridinium compounds
|
|
WO2024206284A2
(en)
|
2023-03-27 |
2024-10-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
WO2024226603A1
(en)
|
2023-04-24 |
2024-10-31 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|